In a filing, Ultragenyx Pharmaceutical Inc. revealed its EVP and Chief Legal Officer Parschauer Karah Herdman unloaded Company’s shares for reported $0.44 million on Jun 12 ’24. In the deal valued at $45.00 per share,9,806 shares were sold. As a result of this transaction, Parschauer Karah Herdman now holds 57,981 shares worth roughly $2.29 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Sanders Corazon (Corsee) D. sold 1,737 shares, generating $71,391 in total proceeds. Upon selling the shares at $41.10, the Director now owns 7,248 shares.
Before that, Crombez Eric sold 354 shares. Ultragenyx Pharmaceutical Inc. shares valued at $15,456 were divested by the EVP and Chief Medical Officer at a price of $43.66 per share. As a result of the transaction, Crombez Eric now holds 48,431 shares, worth roughly $1.91 million.
Goldman upgraded its Ultragenyx Pharmaceutical Inc. [RARE] rating to a Buy from a a Neutral in a research note published on June 06, 2024; the price target was increased to $67 from $56. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in late April with a ‘”an Outperform”‘ rating. Wells Fargo began covering RARE with “an Overweight” recommendation on December 08, 2023.
Price Performance Review of RARE
On Monday, Ultragenyx Pharmaceutical Inc. [NASDAQ:RARE] saw its stock fall -0.45% to $39.42. Over the last five days, the stock has gained 0.95%. Ultragenyx Pharmaceutical Inc. shares have fallen nearly -17.57% since the year began. Nevertheless, the stocks have fallen -23.53% over the past one year. While a 52-week high of $54.56 was reached on 03/01/24, a 52-week low of $31.52 was recorded on 06/18/24. SMA at 50 days reached $41.72, while 200 days put it at $42.46. A total of 0.82 million shares were traded, compared to the trading of 0.97 million shares in the previous session.
Levels Of Support And Resistance For RARE Stock
The 24-hour chart illustrates a support level at 38.93, which if violated will result in even more drops to 38.45. On the upside, there is a resistance level at 40.10. A further resistance level may holdings at 40.79. The Relative Strength Index (RSI) on the 14-day chart is 45.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.70, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.00%. Stochastics %K at 23.26% indicates the stock is a holding.
#####
#####
#####
#####
